Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure Post author: Post published:September 3, 2024 Post category:uncategorized MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients. You Might Also Like Ultra-processed foods: A growing threat to public health February 20, 2024 Researchers develop innovative treatment option for therapy-resistant epilepsy October 8, 2023 Tailoring a computerized decision support system to the ICU environment improves patient safety January 22, 2024
Tailoring a computerized decision support system to the ICU environment improves patient safety January 22, 2024